Segment, Customer and Geographic Information

12 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

Segment, Customer and Geographic Information

Note 14. Segment, Customer and Geographic Information

The Company continues to operate in only one segment, blood safety. The Company’s chief executive officer is the chief operating decision maker who evaluates performance based on the net revenues and operating loss of the blood safety segment. The Company considers the sale of all of its INTERCEPT Blood System products to be similar in nature and function, and any revenue earned from services is minimal.

The Company’s operations outside of the U.S. include a wholly-owned subsidiary headquartered in Europe. The Company’s operations in the U.S. are responsible for the R&D and global and domestic commercialization of the INTERCEPT Blood System, while operations in Europe are responsible for the commercialization efforts of the platelet and plasma systems in Europe, the Commonwealth of Independent States and the Middle East. Product revenues are attributed to each region based on the location of the customer, and in the case of non-product revenues, on the location of the collaboration partner.

The Company had the following significant customers that accounted for more than 10% of the Company’s total product revenue, during the years ended December 31, 2021, 2020 and 2019 (in percentages):

	Year Ended December 31,
	2021	2020	2019
American Red Cross	30%	20%	14%
Établissement Français du Sang	16%	21%	27%

Revenues by geographical location were based on the location of the customer during the years ended December 31, 2021, 2020 and 2019, and was as follows (in thousands):

	Year Ended December 31,
	2021		2020		2019
Product revenue:
United States	$	67,498	$	31,517	$	20,611
France		20,887		19,404		20,075
Other countries		42,474		40,999		33,963
Total product revenue		130,859		91,920		74,649
Government contract revenue:
United States		28,659		22,329		19,125
Total government contract revenue		28,659		22,329		19,125
Total revenue	$	159,518	$	114,249	$	93,774

Long-lived assets by geographical location at December 31, 2021 and December 31, 2020, were as follows (in thousands):

	December 31,
	2021		2020
U.S. and territories	$	11,931	$	13,559
Europe & other		277		308
Total long-lived assets	$	12,208	$	13,867